Literature DB >> 25348176

Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.

M C L G D Thomassen1, A C A Heinzmann, L Herfs, R Hartmann, M Dockal, F Scheiflinger, T M Hackeng, J Rosing.   

Abstract

BACKGROUND: Tissue factor pathway inhibitor-α (TFPIα) inhibits factor Xa by forming a binary TFPI-FXa complex in a reaction that is stimulated by protein S. TF-FVIIa forms a quaternary complex with TFPIα and FXa, which shuts off the initiation of coagulation via the extrinsic pathway. AIM: To investigate whether direct inhibition of FXa by TFPIα independently of TF plays a role in downregulating coagulation.
METHODS: Inhibition of FXa by TFPIα in plasma was determined by measuring thrombin generation triggered with FXa, the FX activator from Russell's viper venom (RVV-X), FXIa, or FIXa. TF-independent anticoagulant activities of TFPIα and its cofactor, protein S, were quantified: (i) after neutralization of TFPIα and protein S with anti-TFPI or anti-protein S antibodies; and (ii) in TFPI-depleted or protein S-depleted plasmas supplemented with varying amounts of TFPIα or protein S.
RESULTS: Both anti-TFPI and anti-protein S antibodies enhanced thrombin generation in plasma triggered with RVV-X, FXa, FIXa, or FXIa. Anti-TFPI and anti-protein S antibodies decreased the lag time and increased the peak height of thrombin generation to the same extent, indicating that inhibition of FXa by TFPIα requires the presence of protein S. TFPIα and protein S titrations in TFPI-depleted or protein S-depleted plasma in which thrombin formation was initiated with triggers other than TF also revealed TF-independent anticoagulant activity of TFPIα, which was completely dependent on the presence of protein S.
CONCLUSION: Direct inhibition of FXa by TFPIα contributes to the downregulation of coagulation.
© 2014 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  TFPIα; blood coagulation; protein S; thrombin; thromboplastin

Mesh:

Substances:

Year:  2014        PMID: 25348176     DOI: 10.1111/jth.12766

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  6 in total

1.  Identification of a new adtrp1-tfpi regulatory axis for the specification of primitive myelopoiesis and definitive hematopoiesis.

Authors:  Li Wang; Xiaojing Wang; Longfei Wang; Muhammad Yousaf; Jia Li; Mengxia Zuo; Zhongcheng Yang; Dongzhi Gou; Binghao Bao; Lei Li; Ning Xiang; Haibo Jia; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  FASEB J       Date:  2017-09-06       Impact factor: 5.191

2.  Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.

Authors:  Pansakorn Tanratana; Paul Ellery; Pamela Westmark; Alan E Mast; John P Sheehan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

3.  Protein S: a Multifunctional Anticoagulant.

Authors:  A'drianne Dorsey; Vijaya Satish Pilli; Howard Fried; Rinku Majumder
Journal:  Biomed Res Clin Pract       Date:  2017-11-20

4.  The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.

Authors:  Marit Hellum; Isabel Franco-Lie; Reidun Øvstebø; Truls Hauge; Carola E Henriksson
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

5.  Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.

Authors:  Bao Q Wang; Meng Shi; Jian P Zhang; Xie Wu; Mei J Chang; Zhi H Chen; Hua H Shen; Yuan L Song; Jian Zhou; Chun X Bai
Journal:  Shock       Date:  2019-02       Impact factor: 3.454

6.  ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI.

Authors:  Qi Shi; Nana Feng; Qingyun Ma; Shaohua Wang; Huijun Zhang; Dayu Huang; Jiayuan Sun; Meng Shi
Journal:  Oxid Med Cell Longev       Date:  2022-07-19       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.